Geron
GERN
0,99 €
Share price
-8.73%
Change (1 day)
-77.11%
Change (1 year)
Categories
Geron (GERN) - Net assets
Net assets on the balance sheet as of March 2025 : €0.23 Billion
According to Geron's latest financial reports the company has €0.23 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Geron - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $€0.26 B | 20.1% |
| 2023-12-31 | $€0.22 B | 200.75% |
| 2022-12-31 | $€74.57 M | -33.19% |
| 2021-12-31 | $€0.11 B | -34.91% |
| 2020-12-31 | $€0.17 B | 42.15% |
| 2019-12-31 | $€0.12 B | -22.34% |
| 2018-12-31 | $€0.15 B | 79.59% |
| 2017-12-31 | $€86.5 M | -25.65% |
| 2016-12-31 | $€0.11 B | -10.49% |
| 2015-12-31 | $€0.12 B | 20.94% |
| 2014-12-31 | $€0.10 B | 148.38% |
| 2013-12-31 | $€43.27 M | -33.18% |
| 2012-12-31 | $€64.75 M | -42.64% |
| 2011-12-31 | $€0.11 B | -22.09% |
| 2010-12-31 | $€0.14 B | 20.29% |
| 2009-12-31 | $€0.12 B | -0.04% |
| 2008-12-31 | $€0.12 B | -14.46% |
| 2007-12-31 | $€0.14 B | 6.87% |
| 2006-12-31 | $€0.13 B | -11.13% |
| 2005-12-31 | $€0.14 B | 64.83% |
| 2004-12-31 | $€89.98 M | 6.55% |
| 2003-12-31 | $€84.45 M | 196.83% |
| 2002-12-31 | $€28.45 M | -59.17% |
| 2001-12-31 | $€69.68 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Eterna Therapeutics ERNA | -€5.14 Million | -102.22% | 🇺🇸 USA |
 Gilead Sciences GILD | €16.45 B | 7,012.34% | 🇺🇸 USA |
 Bio-Techne TECH | €1.74 B | 652.32% | 🇺🇸 USA |
 Incyte INCY | €3.16 B | 1,267.28% | 🇺🇸 USA |
 CTI BioPharma
CTIC | -€21.87 Million | -109.45% | 🇺🇸 USA |